Shenzhen Hepalink Pharmaceutical Group (SHE: 002399)

Shenzhen Hepalink Pharmaceutical Group is a corporation based in Shenzhen, China. Established in 1998, the company manufactures and distributes Heparin Sodium API in the global market to pharmaceutical companies such as Sanofi-Aventis, Fresenius-Kabi, and Novartis. The assets are managed by the board of directors.